Publications by authors named "Meike Brinker"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

659

Total Likes

555

Extended Reach

2,565,224

Social Features

216
F
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Amy K Mottl, Julio Rosenstock, Peter Rossing, Muthiah Vaduganathan, Meike Brinker

N Engl J Med· August 2025

Videos about Article: user user

2 10 204 5 86

View All Article and Social Media Activity
I
Interplay Between Heart Failure Events, New-Onset Diabetes, and Finerenone in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
John W Ostrominski, Henri Lu, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Meike Brinker

Diabetes Care· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of finerenone in Asian patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis by baseline kidney function.
Shigehiro Katayama, Stefan D Anker, Dalong Zhu, SungGyun Kim, Ming-Ju Wu, Meike Brinker

J Diabetes Complications· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure: The FINEARTS-HF Trial.
Finnian R Mc Causland, Safia Chatur, Muthiah Vaduganathan, Brian L Claggett, Ian J Kulac, Meike Brinker

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometric Measures, Cardiovascular Outcomes, and Treatment Effects of Finerenone in Cardiovascular-Kidney-Metabolic Disease: Pooled Participant-Level Analysis of 3 Global Trials.
John W Ostrominski, Josephine Harrington, Brian L Claggett, Gerasimos Filippatos, Akshay S Desai, Meike D Brinker

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction and Safety With Simultaneous Initiation of Finerenone and Empagliflozin in Type 2 Diabetes and Chronic Kidney Disease (CONFIDENCE Trial).
Rajiv Agarwal, Jennifer B Green, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Meike Brinker

Diabetes Care· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Cardiovascular and Kidney Benefits With Finerenone in Heart Failure and Chronic Kidney Disease With Type 2 Diabetes.
John W Ostrominski, Brendon L Neuen, Brian L Claggett, Gerasimos Filippatos, Akshay S Desai, Meike Brinker

J Am Coll Cardiol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interplay of serum potassium and kidney function with finerenone in heart failure with mildly reduced or preserved ejection fraction: Findings from FINEARTS-HF.
João Pedro Ferreira, Muthiah Vaduganathan, Brian L Claggett, Ian Kulac, John W Ostrominski, Meike Brinker

Eur J Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial.
John W Ostrominski, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Carolyn S P Lam, Meike Brinker

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Finerenone on Morbidity and Mortality in CKD.
John W Ostrominski, Gerasimos Filippatos, Brian L Claggett, Zi Michael Miao, Akshay S Desai, Meike D Brinker

J Am Soc Nephrol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations.
Hiddo J L Heerspink, Rajiv Agarwal, Antonio J Amor, Jesper N Bech, David Z I Cherney, Meike Brinker

Nephrol Dial Transplant· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy of finerenone on hierarchical composite endpoint analysed using win statistics in patients with heart failure and mildly reduced or preserved ejection fraction: A prespecified analysis of FINEARTS-HF.
Toru Kondo, Pardeep S Jhund, Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Meike Brinker

Eur J Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Finerenone in Heart Failure With Preserved Ejection Fraction: A FINE-HEART Analysis.
John W Ostrominski, Gerasimos Filippatos, Brian L Claggett, Zi Michael Miao, Akshay S Desai, Meike Brinker

JACC Heart Fail· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.
Shingo Matsumoto, Alasdair D Henderson, Pardeep S Jhund, Johann Bauersachs, Ovidiu Chioncel, Meike Brinker

JAMA Cardiol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone, glycaemic status, and heart failure with mildly reduced or preserved ejection fraction: A prespecified analysis of the FINEARTS-HF trial.
Jawad H Butt, Pardeep S Jhund, Alasdair D Henderson, Brian L Claggett, Akshay S Desai, Meike Brinker

Eur J Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis.
Sankar D Navaneethan, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Meike Brinker

Kidney Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of the glomerular filtration rate slope to the kidney hierarchical composite endpoint.
Dustin J Little, Niels Jongs, Meike Brinker, Samvel B Gasparyan, Patrick Schloemer

Kidney Int· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of eGFR Slope Thresholds as End Point Components in a Kidney Disease Progression Hierarchical Composite End Point.
Niels Jongs, Samvel B Gasparyan, Lars Frison, Patrick Schloemer, Meike Brinker

J Am Soc Nephrol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Finerenone in Type 2 Diabetes: A Pooled Analysis of Trials of Heart Failure and Chronic Kidney Disease.
John W Ostrominski, Brian L Claggett, Zi Michael Miao, Gerasimos Filippatos, Akshay S Desai, Meike Brinker

Diabetes Care· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome: The FINE-HEART Pooled Analysis.
Maria A Pabon, Gerasimos Filippatos, Brian L Claggett, Michael Zi Miao, Akshay S Desai, Meike Brinker

J Am Coll Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis.
Ping Li, Hongguang Zheng, Jianhua Ma, Weiping Lu, Ling Li, Meike Brinker

Front Endocrinol (Lausanne)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Finerenone in Asian Patients with Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis.
Takashi Wada, Stefan D Anker, Zhihong Liu, Byung Wan Lee, Chien-Te Lee, Meike Brinker

Kidney Dis (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between intercurrent events and cardiorenal clinical outcomes in non-diabetic chronic kidney disease: a real-world retrospective cohort study in the United States.
Christoph Wanner, Johannes Schuchhardt, Chris Bauer, Meike Brinker, Frank Kleinjung

BMC Nephrol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial.
John W Ostrominski, Finnian R Mc Causland, Brian L Claggett, Akshay S Desai, Pardeep S Jhund, Meike Brinker

JACC Heart Fail· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident hyperkalaemia risk model in chronic kidney disease and diabetes: the FIDELITY programme.
João Pedro Ferreira, Stefan D Anker, Biff F Palmer, Bertram Pitt, Peter Rossing, Meike Brinker

Eur Heart J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis